Patient Guide: Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 219 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06211036
Status: ACTIVE_NOT_RECRUITING
Condition: Extensive-Stage Small-Cell Lung Cancer, Small-Cell Lung Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 219 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Mobile, Alabama
  • Los Angeles, California
  • New Haven, Connecticut
  • • And 216 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily